Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

Details for Australian Patent Application No. 2001268719 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Dahan, Mazal; Rosenberger, Vered; Lerner, Yitzhak

Agent Shelston IP

Pub. Number AU-B-2001268719

PCT Pub. Number WO02/00204

Priority 60213832 23.06.00 US; 60260438 09.01.01 US; 09770898 26.01.01 US

Filing date 22 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 27 April 2006

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/34 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

27 April 2006 Application Accepted

  Published as AU-B-2001268719

31 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268720-Particle entrapment system

2001268718-Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immunesuppressive agents